Heart Institute, Hospital of Clinics, São Paulo University Medical School
São Paulo, 05403-000, Brazil
NCT Number: NCT01178866
Evaluate less employed markers of tissue hypoperfusion as venoarterial carbon dioxide partial pressure difference (ΔPCO2) and estimated respiratory quotient (eRQ) combined to other classically studied markers as predictive factors of complicated clinical course after cardiac surgery in patients with left ventricular dysfunction.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
São Paulo, 05403-000, Brazil
Patients with left ventricular dysfunction are more susceptible to tissue hypoperfusion and presents more frequently both low cardiac output syndrome and systemic inflammatory response, what results in prolonged stay in intensive care unit (ICU), and higher mortality rates when compared to patients with normal ventricular function.
The early prediction of prolonged ICU stay through the detection of tissue hypoperfusion may improve the management of care and decrease morbidity of this particular group of patients. However, classic markers of tissue hypoxia as central venous saturation, base excess, lactate may not be predictors of outcome in cardiac surgery patients with left ventricular dysfunction.
The question addressed in this study is if less employed markers of tissue hypoperfusion as as venoarterial carbon dioxide partial pressure difference (ΔPCO2) and estimated respiratory quotient (eRQ) have predictive value of prolonged ICU stay in patients with left ventricular dysfunction submitted to coronary artery bypass surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: within the first 30 days after surgery
Complicated clinical course defined as death within the first 30 days after surgery or ICU stay more than 4 days.
University of Sao Paulo
Other
Markers of Tissue Perfusion as Predictors of Complicated Evolution in Patients With Left Ventricular Dysfunction Submitted to Coronary Artery Bypass Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07515859
Cancer Therapy-related Cardiac Dysfunction, Cardiotoxicity
Seoul, South Korea
View Trial DetailsNCT07519434
Cardiac Remodeling, Cardiovascular Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04774523
Arrhythmias, Cardiac, Cardiac Arrhythmia
Burgos, Castille and León, Spain
View Trial DetailsNCT03319160
Cardiac Arrythmias, Cardiac Event
Paris, France
View Trial Details